The Carr’s Group has reported increased half year profitability and revenues from continuing operations, in what has been a transformative period for the business. It is considering the closure of its loss-making Animax bolus…
To read the full story and access every news article on the site, SUBSCRIBE NOW!
From now on, you can get a trial subscription for just £1